Company: TYRA
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001193125-25-085709
Chunk: 3

Company: Tyra Biosciences, Inc.
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 3
---
 now will not prevent you from voting your shares at the Annual Meeting if you desire to do so, as your proxy is revocable at your option. For specific voting instructions, please refer to the information provided in the accompanying Proxy Statement and in the Notice of Internet Availability of Proxy Materials. By Order of the Board of Directors,

| Todd Harris                                     |
| President, Chief Executive Officer and Director |
| Carlsbad, California                            |
| April 18, 2025                                  |

#### TABLE OF CONTENTSPageGENERAL1PROPOSAL 1: ELECTION OF DIRECTORS7PROPOSAL 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM12EXECUTIVE OFFICERS14EXECUTIVE AND DIRECTOR COMPENSATION22SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT31CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS342026 STOCKHOLDER PROPOSALS36TYRA’S ANNUAL REPORT ON FORM10-K37
PROXY STATEMENT TYRA BIOSCIENCES, INC. 2656 State Street, Carlsbad, California 92008 General This proxy statement is furnished in connection with the solicitation by the board of directors (the “Board”) of Tyra Biosciences, Inc. of proxies to be voted at our Annual Meeting of Stockholders to be held virtually on Thursday, May 29, 2025 (the “Annual Meeting”), at 10:00 a.m., Pacific Time, and at any continuation, postponement or adjournment thereof. Holders of record of shares of our common stock, $0.0001 par value per share (“Common Stock”), as of the close of business on April 4, 2025 (the “Record Date”), will be entitled to notice of and to vote at the Annual Meeting and any continuation, postponement or adjournment thereof. As of the Record Date, there were 53,089,957 shares of our Common Stock outstanding and entitled to vote at the Annual Meeting. Each share of Common Stock is entitled to one vote on any matter presented to stockholders at the Annual Meeting. This proxy statement and the Company’s Annual Report to Stockholders for the year ended December 31, 2024 (the “2024 Annual Report”), or Notice of Internet Availability of Proxy Materials, as applicable, will be sent on or about April 18, 2025 to our stockholders on the Record Date. In this proxy statement, “